ASHG 2026 · Tools, software & services

FinnGen at ASHG 2026

Name: ASHG 2026 Annual Meeting
Start: 2026-10-20
End: 2026-10-24
Location: Montréal

Helsinki, Finland

FinnGen at ASHG 2026 in Montréal: Booth 1617.

1617

exhibit booth

Organization

ASHG 2026 Attendance

Helsinki, Finland

~40 people

FinnGen builds a large-scale genomic and health-data resource for academic researchers, biopharma partners, drug discovery, and genome medicine.

A FinnGen study identified a genetic marker for blood-pressure drug intolerance, moving personalized hypertension treatment closer to practice.

›

A FinnGen study identified a genetic marker for blood-pressure drug intolerance, moving personalized hypertension treatment closer to practice.

2026-08 · source

Found that polygenic risk scores can identify people at substantially higher risk of glaucoma and faster disease progression.

2026-07 · source

Released Data Freeze 13, expanding its public GWAS resource to 2,755 endpoints across more than 500,000 participants and 21 million variants.

2026-06 · source

Approx. €157M total project budget

›

Figure is the overall FinnGen project budget, not a single-year revenue or funding-round figure.

“~157 M€”

Booth

Exhibiting at Booth 1617

Wed, Oct 219:45am–4:30pmThu, Oct 229:45am–1:30pmFri, Oct 239:45am–4:30pm

Get in-depth attendee and institution profiles and research, to plan your meetings in Montréal. Leave your work email and we’ll be in touch.

Not affiliated with or endorsed by the American Society of Human Genetics. Submit a correction